Amgen: A Global Biopharmaceutical Company
Amgen is a biopharmaceutical company based in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics Inc., Amgen’s primary focus is the development and manufacture of innovative medicines that address serious illnesses. The company has grown to become one of the world’s largest independent biotechnology companies, with over 10,000 employees worldwide and annual revenues exceeding $20 billion USD.
Products and Therapeutic Areas Covered by Amgen
Amgen focuses on major therapeutic areas such as cancer, inflammation/immunology, bone health/metabolic diseases and neuroscience. Their product range encompasses small molecules (such as Enbrel® for rheumatoid arthritis) as well as larger proteins (like Neulasta® which helps reduce infection risk during chemotherapy). In addition to these products already on the market, Amgen continues its efforts in research & development to bring new therapies to those suffering from life-threatening medical conditions.
Research & Development at Amgen
Amgen invests heavily into research & development each year – estimated at around 20% of their total revenue – with a particular emphasis on early stage projects related to potential treatments for unmet medical needs such as cardiovascular disease or chronic pain management. This investment allows them access to cutting edge technologies and collaborations with academic institutions across the globe that have resulted in several breakthrough discoveries since their establishment nearly four decades ago; most notably immunotherapies like Prolia®, Xgeva®, Kyprolis® (for multiple myeloma)and Repatha® (for cholesterol management).
Conclusion
As evidenced by their expansive portfolio of approved drugs addressing many debilitating diseases, Amgent remains an influential player within the global biopharmaceutical industry due largely to its commitment towards advancing science through novel drug discovery programs coupled with efficient manufacturing capabilities that ensure safe production of quality therapies for patients around the world.